Department of Biomedical Sciences

Permanent URI for this community

https://scholar.sun.ac.za/handle/10019.1/137

Browse

Browsing Department of Biomedical Sciences by Subject "Abdominal aorta"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Pharmacological inhibition of Notch signaling regresses pre-established abdominal aortic aneurysm
    (Nature Research, 2019-09-17) Sharma, Neekun; Dev, Rishabh; Ruiz-Rosado, Juan de Dios; Partida-Sanchez, Santiago; Guerau-de-Arellano, Mireia; Dhakal, Pramod; Kuivaniemi, Helena; Hans, Chetan P.
    ENGLISH ABSTRACT: Abdominal aortic aneurysm (AAA) is characterized by transmural infiltration of myeloid cells at the vascular injury site. Previously, we reported preventive effects of Notch deficiency on the development of AAA by reduction of infiltrating myeloid cells. In this study, we examined if Notch inhibition attenuates the progression of pre-established AAA and potential implications. Pharmacological Notch inhibitor (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester; DAPT) was administered subcutaneously three times a week starting at day 28 of angiotensin II (AngII) infusion. Progressive increase in pulse wave velocity (PWV), maximal intra-luminal diameter (MILD) and maximal external aortic diameter (MEAD) were observed at day 56 of the AngII. DAPT prevented such increase in MILD, PWV and MEAD (P < 0.01). Histologically, the aortae of DAPT-treated Apoe−/− mice had significant reduction in inflammatory response and elastin fragmentation. Naked collagen microfibrils and weaker banded structure observed in the aortae of Apoe−/− mice in response to AngII, were substantially diminished by DAPT. A significant decrease in the proteolytic activity in the aneurysmal tissues and vascular smooth muscle cells (vSMCs) was observed with DAPT (P < 0.01). In human and mouse AAA tissues, increased immunoreactivity of activated Notch signaling correlated strongly with CD38 expression (R2 = 0.61). Collectively, we propose inhibition of Notch signaling as a potential therapeutic target for AAA progression.